对穿孔性胃潰瘍的治疗方法:随机对照试验的网络元分析 - 研究协议
Elisabeth Wadewitz1, Juliane Friedrichs2, Maurizio Grilli3
1University Hospital Halle (Saale), Germany, Department of Visceral, Vascular and Endocrine Surgery, Martin Luther University Halle Wittenberg, Halle, Germany.
BMJ open
|March 19, 2024
概括
这个网络元分析比较了穿孔性胃的手术和替代治疗方法. 它的目的是确定最有效的方法来降低死亡率和改善患者的治疗结果.
科学领域:
- 胃肠病学和外科手术
- 临床流行病学临床流行病学
背景情况:
- 穿孔性胃潰瘍代表了具有重大死亡率和發病率的關鍵醫療緊急情況.
- 存在各种治疗策略,需要进行比较分析.
研究的目的:
- 进行一个网络元分析 (NMA),比较穿孔性胃的手术和替代干预措施.
- 评估治疗疗效的死亡率和其他以患者为中心的结果.
主要方法:
- 将在多个数据库 (PubMed/MEDLINE,Embase,Cochrane图书馆等) 进行全面的系统文献搜索. ) 的情况.
- 网络元分析将用于综合符合条件的研究数据.
- 标准化的平均差异和几率比率,以95%的置信区间将分别用于连续和二进制结果.
主要成果:
- 分析将为不同的治疗方式提供比较有效性数据.
- 将评估包括死亡率在内的关键结果.
结论:
- 这些发现将为最佳管理穿孔性胃潰瘍的临床决策提供信息.
- 结果将通过出版物和会议演讲传播给医疗保健专业人员.
更多相关视频
相关概念视频
Peptic Ulcer Disease IV: Management
91
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
91
Peptic Ulcer Disease V: Surgical Management and Nursing Care
303
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
303
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
434
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
434
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
396
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
396
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
117
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
117
Peptic Ulcer Disease I: Introduction
168
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
168


